Protagonist Therapeutics, Inc. | ||||
NGM : PTGX || Location: United States | ||||
$28.48+0.48 (+1.71%) |
0.36 M | 27.94 - 28.62 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
Feb. 29, 2024 | 2.936 M |
Feb. 15, 2024 | 2.780 M |
Jan. 31, 2024 | 2.610 M |
Jan. 12, 2024 | 2.552 M |
Dec. 29, 2023 | 2.347 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.03 | 0.44 | 1397.94% |
09/30/2023 | -0.71 | -0.58 | 18.04% |
06/30/2023 | -0.66 | -0.68 | -2.98% |
03/31/2023 | -0.74 | -0.67 | 9.61% |
12/31/2022 | -0.65 | -0.69 | -5.97% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 58.275M | Shares Float | 40.636M |
Short Float | 2.936M | Market Cap | 1659.67M |
Institution ownership | 0.00% | Insider ownership | 1.750% |
Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.39 | Forward EPS | -0.81 |